Global Nuclear Molecular Imaging System Market Research Report 2023

Publication ID:

PB510243456

Publication Date:

October 12, 2023

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

The global Nuclear Molecular Imaging System market is projected to reach US$ 3619 million in 2029, increasing from US$ 2294 million in 2022, with the CAGR of 7.1% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Nuclear Molecular Imaging System 91制片厂.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Nuclear Molecular Imaging System market with multiple angles, which provides sufficient supports to readers鈥� strategy and decision making.
By Company
Bruker
GE Healthcare
Siemens Healthcare
Philips Healthcare
Canon Medical Systems
Hitachi Medical
Digirad Corporation
DDD-Diagnostics A/S
Neusoft Medical Systems Co. Ltd.
Mediso Medical Imaging Systems, Ltd.
SurgicEye GmbH
CMR Naviscan Corporation
Segment by Type
Positron Emission Tomography
Single-photon Emission Computed Tomography
Planar Scintigraphy Systems
Segment by Application
Oncology
Cardiology
Neurology
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Nuclear Molecular Imaging System report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers鈥� Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers鈥� Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Nuclear Molecular Imaging System Market Overview
1.1 Product Overview and Scope of Nuclear Molecular Imaging System
1.2 Nuclear Molecular Imaging System Segment by Type
1.2.1 Global Nuclear Molecular Imaging System Market Value Comparison by Type (2023-2029)
1.2.2 Positron Emission Tomography
1.2.3 Single-photon Emission Computed Tomography
1.2.4 Planar Scintigraphy Systems
1.3 Nuclear Molecular Imaging System Segment by Application
1.3.1 Global Nuclear Molecular Imaging System Market Value by Application: (2023-2029)
1.3.2 Oncology
1.3.3 Cardiology
1.3.4 Neurology
1.3.5 Others
1.4 Global Nuclear Molecular Imaging System Market Size Estimates and Forecasts
1.4.1 Global Nuclear Molecular Imaging System Revenue 2018-2029
1.4.2 Global Nuclear Molecular Imaging System Sales 2018-2029
1.4.3 Global Nuclear Molecular Imaging System Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Nuclear Molecular Imaging System Market Competition by Manufacturers
2.1 Global Nuclear Molecular Imaging System Sales Market Share by Manufacturers (2018-2023)
2.2 Global Nuclear Molecular Imaging System Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Nuclear Molecular Imaging System Average Price by Manufacturers (2018-2023)
2.4 Global Nuclear Molecular Imaging System Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Nuclear Molecular Imaging System, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Nuclear Molecular Imaging System, Product Type & Application
2.7 Nuclear Molecular Imaging System Market Competitive Situation and Trends
2.7.1 Nuclear Molecular Imaging System Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Nuclear Molecular Imaging System Players Market Share by Revenue
2.7.3 Global Nuclear Molecular Imaging System Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Nuclear Molecular Imaging System Retrospective Market Scenario by Region
3.1 Global Nuclear Molecular Imaging System Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Nuclear Molecular Imaging System Global Nuclear Molecular Imaging System Sales by Region: 2018-2029
3.2.1 Global Nuclear Molecular Imaging System Sales by Region: 2018-2023
3.2.2 Global Nuclear Molecular Imaging System Sales by Region: 2024-2029
3.3 Global Nuclear Molecular Imaging System Global Nuclear Molecular Imaging System Revenue by Region: 2018-2029
3.3.1 Global Nuclear Molecular Imaging System Revenue by Region: 2018-2023
3.3.2 Global Nuclear Molecular Imaging System Revenue by Region: 2024-2029
3.4 North America Nuclear Molecular Imaging System Market Facts & Figures by Country
3.4.1 North America Nuclear Molecular Imaging System Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Nuclear Molecular Imaging System Sales by Country (2018-2029)
3.4.3 North America Nuclear Molecular Imaging System Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Nuclear Molecular Imaging System Market Facts & Figures by Country
3.5.1 Europe Nuclear Molecular Imaging System Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Nuclear Molecular Imaging System Sales by Country (2018-2029)
3.5.3 Europe Nuclear Molecular Imaging System Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Nuclear Molecular Imaging System Market Facts & Figures by Country
3.6.1 Asia Pacific Nuclear Molecular Imaging System Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Nuclear Molecular Imaging System Sales by Country (2018-2029)
3.6.3 Asia Pacific Nuclear Molecular Imaging System Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Nuclear Molecular Imaging System Market Facts & Figures by Country
3.7.1 Latin America Nuclear Molecular Imaging System Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Nuclear Molecular Imaging System Sales by Country (2018-2029)
3.7.3 Latin America Nuclear Molecular Imaging System Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Nuclear Molecular Imaging System Market Facts & Figures by Country
3.8.1 Middle East and Africa Nuclear Molecular Imaging System Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Nuclear Molecular Imaging System Sales by Country (2018-2029)
3.8.3 Middle East and Africa Nuclear Molecular Imaging System Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Nuclear Molecular Imaging System Sales by Type (2018-2029)
4.1.1 Global Nuclear Molecular Imaging System Sales by Type (2018-2023)
4.1.2 Global Nuclear Molecular Imaging System Sales by Type (2024-2029)
4.1.3 Global Nuclear Molecular Imaging System Sales Market Share by Type (2018-2029)
4.2 Global Nuclear Molecular Imaging System Revenue by Type (2018-2029)
4.2.1 Global Nuclear Molecular Imaging System Revenue by Type (2018-2023)
4.2.2 Global Nuclear Molecular Imaging System Revenue by Type (2024-2029)
4.2.3 Global Nuclear Molecular Imaging System Revenue Market Share by Type (2018-2029)
4.3 Global Nuclear Molecular Imaging System Price by Type (2018-2029)
5 Segment by Application
5.1 Global Nuclear Molecular Imaging System Sales by Application (2018-2029)
5.1.1 Global Nuclear Molecular Imaging System Sales by Application (2018-2023)
5.1.2 Global Nuclear Molecular Imaging System Sales by Application (2024-2029)
5.1.3 Global Nuclear Molecular Imaging System Sales Market Share by Application (2018-2029)
5.2 Global Nuclear Molecular Imaging System Revenue by Application (2018-2029)
5.2.1 Global Nuclear Molecular Imaging System Revenue by Application (2018-2023)
5.2.2 Global Nuclear Molecular Imaging System Revenue by Application (2024-2029)
5.2.3 Global Nuclear Molecular Imaging System Revenue Market Share by Application (2018-2029)
5.3 Global Nuclear Molecular Imaging System Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Bruker
6.1.1 Bruker Corporation Information
6.1.2 Bruker Description and Business Overview
6.1.3 Bruker Nuclear Molecular Imaging System Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Bruker Nuclear Molecular Imaging System Product Portfolio
6.1.5 Bruker Recent Developments/Updates
6.2 GE Healthcare
6.2.1 GE Healthcare Corporation Information
6.2.2 GE Healthcare Description and Business Overview
6.2.3 GE Healthcare Nuclear Molecular Imaging System Sales, Revenue and Gross Margin (2018-2023)
6.2.4 GE Healthcare Nuclear Molecular Imaging System Product Portfolio
6.2.5 GE Healthcare Recent Developments/Updates
6.3 Siemens Healthcare
6.3.1 Siemens Healthcare Corporation Information
6.3.2 Siemens Healthcare Description and Business Overview
6.3.3 Siemens Healthcare Nuclear Molecular Imaging System Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Siemens Healthcare Nuclear Molecular Imaging System Product Portfolio
6.3.5 Siemens Healthcare Recent Developments/Updates
6.4 Philips Healthcare
6.4.1 Philips Healthcare Corporation Information
6.4.2 Philips Healthcare Description and Business Overview
6.4.3 Philips Healthcare Nuclear Molecular Imaging System Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Philips Healthcare Nuclear Molecular Imaging System Product Portfolio
6.4.5 Philips Healthcare Recent Developments/Updates
6.5 Canon Medical Systems
6.5.1 Canon Medical Systems Corporation Information
6.5.2 Canon Medical Systems Description and Business Overview
6.5.3 Canon Medical Systems Nuclear Molecular Imaging System Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Canon Medical Systems Nuclear Molecular Imaging System Product Portfolio
6.5.5 Canon Medical Systems Recent Developments/Updates
6.6 Hitachi Medical
6.6.1 Hitachi Medical Corporation Information
6.6.2 Hitachi Medical Description and Business Overview
6.6.3 Hitachi Medical Nuclear Molecular Imaging System Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Hitachi Medical Nuclear Molecular Imaging System Product Portfolio
6.6.5 Hitachi Medical Recent Developments/Updates
6.7 Digirad Corporation
6.6.1 Digirad Corporation Corporation Information
6.6.2 Digirad Corporation Description and Business Overview
6.6.3 Digirad Corporation Nuclear Molecular Imaging System Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Digirad Corporation Nuclear Molecular Imaging System Product Portfolio
6.7.5 Digirad Corporation Recent Developments/Updates
6.8 DDD-Diagnostics A/S
6.8.1 DDD-Diagnostics A/S Corporation Information
6.8.2 DDD-Diagnostics A/S Description and Business Overview
6.8.3 DDD-Diagnostics A/S Nuclear Molecular Imaging System Sales, Revenue and Gross Margin (2018-2023)
6.8.4 DDD-Diagnostics A/S Nuclear Molecular Imaging System Product Portfolio
6.8.5 DDD-Diagnostics A/S Recent Developments/Updates
6.9 Neusoft Medical Systems Co. Ltd.
6.9.1 Neusoft Medical Systems Co. Ltd. Corporation Information
6.9.2 Neusoft Medical Systems Co. Ltd. Description and Business Overview
6.9.3 Neusoft Medical Systems Co. Ltd. Nuclear Molecular Imaging System Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Neusoft Medical Systems Co. Ltd. Nuclear Molecular Imaging System Product Portfolio
6.9.5 Neusoft Medical Systems Co. Ltd. Recent Developments/Updates
6.10 Mediso Medical Imaging Systems, Ltd.
6.10.1 Mediso Medical Imaging Systems, Ltd. Corporation Information
6.10.2 Mediso Medical Imaging Systems, Ltd. Description and Business Overview
6.10.3 Mediso Medical Imaging Systems, Ltd. Nuclear Molecular Imaging System Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Mediso Medical Imaging Systems, Ltd. Nuclear Molecular Imaging System Product Portfolio
6.10.5 Mediso Medical Imaging Systems, Ltd. Recent Developments/Updates
6.11 SurgicEye GmbH
6.11.1 SurgicEye GmbH Corporation Information
6.11.2 SurgicEye GmbH Nuclear Molecular Imaging System Description and Business Overview
6.11.3 SurgicEye GmbH Nuclear Molecular Imaging System Sales, Revenue and Gross Margin (2018-2023)
6.11.4 SurgicEye GmbH Nuclear Molecular Imaging System Product Portfolio
6.11.5 SurgicEye GmbH Recent Developments/Updates
6.12 CMR Naviscan Corporation
6.12.1 CMR Naviscan Corporation Corporation Information
6.12.2 CMR Naviscan Corporation Nuclear Molecular Imaging System Description and Business Overview
6.12.3 CMR Naviscan Corporation Nuclear Molecular Imaging System Sales, Revenue and Gross Margin (2018-2023)
6.12.4 CMR Naviscan Corporation Nuclear Molecular Imaging System Product Portfolio
6.12.5 CMR Naviscan Corporation Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Nuclear Molecular Imaging System Industry Chain Analysis
7.2 Nuclear Molecular Imaging System Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Nuclear Molecular Imaging System Production Mode & Process
7.4 Nuclear Molecular Imaging System Sales and Marketing
7.4.1 Nuclear Molecular Imaging System Sales Channels
7.4.2 Nuclear Molecular Imaging System Distributors
7.5 Nuclear Molecular Imaging System Customers
8 Nuclear Molecular Imaging System Market Dynamics
8.1 Nuclear Molecular Imaging System Industry Trends
8.2 Nuclear Molecular Imaging System Market Drivers
8.3 Nuclear Molecular Imaging System Market Challenges
8.4 Nuclear Molecular Imaging System Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

Bruker
GE Healthcare
Siemens Healthcare
Philips Healthcare
Canon Medical Systems
Hitachi Medical
Digirad Corporation
DDD-Diagnostics A/S
Neusoft Medical Systems Co. Ltd.
Mediso Medical Imaging Systems, Ltd.
SurgicEye GmbH
CMR Naviscan Corporation

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.